Redoxis expands functional readouts with CatWalk XT 🎉

We are proud to share that Redoxis has invested in the CatWalk XT automated gait analysis system from Noldus Information Technology.

Functional outcome measures are becoming increasingly important in preclinical research — particularly in models of neuroinflammation, pain, arthritis, and peripheral neuropathy. With CatWalk XT, we can now capture highly sensitive and objective gait parameters that complement our established clinical scoring and histopathology endpoints.

This strengthens our ability to:
• Detect subtle motor and sensory deficits from a rich and multi-parametric data set
• Generate reproducible, operator-independent functional data
• Improve translational relevance
• Detect treatment effects earlier and with greater precision
• Integrate functional readouts with clinical and tissue-level data

For our partners, this means deeper insights and stronger decision-enabling datasets when evaluating therapeutic candidates.

At Redoxis we continue to invest in technologies that strengthen the scientific quality and translational relevance of the data we generate.

If you are working in neuroinflammation, arthritis, neuropathy, or pain models, I would be happy to connect and discuss how we can support your program.